| BCBS Federal Medical & Drug | 5.21.089 Bavencio (avelumab) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.092 Alunbrig (brigatinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.093 Rydapt (midostaurin) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.094 Imfinzi (durvalumab) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.095 Sutent (sunitinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.096 Rituxan Hycela (rituximab and hyaluronidase) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.097 Nerlynx (neratinib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.098 Idhifa (enasidenib) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.099 Vyxeos (daunorubicin and cytarabine) | 2026-03-06 |
| BCBS Federal Medical & Drug | 5.21.100 Besponsa (inotuzumab ozogamicin) | 2026-03-06 |